OneRail, Tenstorrent, and Maze Therapeutics: Series C+ Funding and Future Plans

The Growth Investor Daily Brief
04/12/2024 5 min Episodio 7

Listen "OneRail, Tenstorrent, and Maze Therapeutics: Series C+ Funding and Future Plans"

Descargar episodio Ver en sitio original

Episode Synopsis

Michelle welcomes listeners to the latest episode of The Growth Investor Daily Brief, diving into recent Series C+ funding updates. The episode covers OneRail's efforts in optimizing last-mile delivery and their funding plans, as well as Tenstorrent's Series D success in the AI chip sector. Additionally, Maze Therapeutics' Series D financing and their future strategic plans are discussed. The episode wraps up with investor insights, providing listeners with essential information to stay informed about the evolving investment landscape.

More episodes of the podcast The Growth Investor Daily Brief

Axiado, ModifyHealth, Cleerly, and Tenstorrent: Series C+ Funding Highlights and Future Prospects 06/12/2024
Tractian, Tenstorrent, and Maze Therapeutics: Series C+ Funding Highlights 05/12/2024
Halcyon and Tenstorrent: Series C and D Funding Rounds & AI Innovation Insights 03/12/2024
Eon's $70M Series C Raise: Funding Highlights and Future Plans 02/12/2024
Latest Series C+ Funding Highlights with a Spotlight on Eon 28/11/2024
Series C+ funding highlights: Spectro Cloud and Sirona Medical's latest successes 27/11/2024
Series C+ funding highlights: Halcyon, Lighthouse, Infinitus Systems, and Firefly Aerospace 26/11/2024
Series C funding highlights: Halcyon, Lighthouse, Infinitus Systems, and KoRo Handels GmbH 25/11/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA